Molbio Diagnostics
Molbio Diagnostics Share Price Chart
Molbio Diagnostics last traded at ₹1,437.30 (2026-10-13). Over the past month the stock moved -4.8%. Its closing range over 52 weeks is ₹1,032.40 – ₹1,544.35, with the latest close 6.9% below the high.
Closing prices up to 2026-10-13.
About Molbio Diagnostics
Molbio Diagnostics is an innovative point- of-care (POC) diagnostics company that develops affordable, rapid, and accurate diagnostic solutions for infectious and non-communicable diseases. Its flagship product, Truenat, is a portable, battery-powered PCR testing platform that delivers results within an hour. Designed for use in resource-limited settings, it enables quick and decentralised disease diagnosis at the point of care.
Fundamentals
Quarterly Results
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 408.00 | 101.00 | 25.00 | 53.00 | 5.21 |
| Mar 2026 | 561.00 | 159.00 | 28.00 | 96.00 | 8.06 |
| Jun 2025 | 100.00 | -16.00 | -16.00 | -24.00 | -10.51 |
Annual Financials
In the latest year (Mar 2026), Molbio Diagnostics reported sales of ₹1,446.00 crore (+41.8%) and net profit of ₹164.00 crore (+18.0%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 1,446 | 320.00 | 22.00 | 164.00 | 14.77 |
| Mar 2025 | 1,020 | 260.00 | 26.00 | 139.00 | 64.34 |
| Mar 2024 | 837.00 | 234.00 | 28.00 | 84.00 | 452.37 |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Sales growth | +21.9% | +41.8% |
| Operating profit growth | +11.1% | +23.1% |
| Net profit growth | +65.5% | +18.0% |
| EPS growth | -85.8% | -77.0% |
| OPM % | 26.0% | 22.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Molbio Diagnostics.
Get Free AI Stock Analysis FREE →Latest News
-
MFs deployed over Rs 8,800 crore in 18 IPOs in August: ESDS Software Solution, Molbio Diagnostics and more - The Economic Times
-
MFs deployed over Rs 8,800 crore in 18 IPOs in August: ESDS Software Solution, Molbio Diagnostics and more - The Economic Times
-
Recently listed Molbio Diagnostics share price falls 9%: Healthcare stock loses 18.5% in 2 days after blockbuster rally
-
Molbio Diagnostics shares surge over 50% in just 3 days! What is driving the rally?
-
Price Band Hitters, September 10, 2026 at 4:00 PM IST: ESDS Software Solution, Molbio Diagnostics Lead the List
-
Molbio Diagnostics hits 20% upper circuit on heavy volume; up 35% in 2 days - Business Standard
-
Price Band Hitters on September 10, 2026 at 12:00 PM: Molbio Diagnostics Leads the List
-
Molbio Diagnostics shares rally 30% in 2 days, jump 80% since debut. What lies ahead? - The Economic Times
-
Molbio Diagnostics share price hits 20% upper circuit, jumps 87% from IPO price
-
Newly-Listed Molbio Diagnostics Posts Rs 52.7 Cr Profit in Q1
Frequently Asked Questions
What is Molbio Diagnostics's current stock price?
Molbio Diagnostics shares were last quoted at ₹1,437.30 (-0.1% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Molbio Diagnostics?
Molbio Diagnostics has a price-to-earnings (P/E) ratio of 0.00 and a price-to-book (P/B) ratio of 12.28. The industry P/E is 101.02.
What is the 52-week high and low of Molbio Diagnostics?
The 52-week high of Molbio Diagnostics is ₹1,686.50 and the 52-week low is ₹925.80.
What is the market cap of Molbio Diagnostics?
The market capitalisation of Molbio Diagnostics is about ₹14,360.63 crore.
Is Molbio Diagnostics a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Molbio Diagnostics has a 3-year ROE of 16.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Molbio Diagnostics?
Promoters hold about 41.29% of Molbio Diagnostics.
Which sector does Molbio Diagnostics belong to?
Molbio Diagnostics belongs to the Medical Equipment/Supplies/Accessories sector.
Other Medical Equipment/Supplies/Accessories stocks
- Poly Medicure
- Indegene
- Aarti Pharmalabs
- Q-Line Biotech
- Hemant Surgical Industries
- Prevest Denpro
- QMS Medical Allied Services
- Nureca
All Medical Equipment/Supplies/Accessories stocks · Browse all stocks A–Z